Abstract
Objective To analyze mortality trends in Switzerland in 2021, the second year of the COVID-19 pandemic.
Methods Using data from the Swiss Federal Statistical Office, we compared mortality in Switzerland in 2021 with that of previous years in terms of standardized weekly deaths, standardized (annual) mortality rates (overall and stratified by age and sex) and life expectancy.
Results After a favorable first half of the year and a fairly standard second half in terms of mortality in Switzerland, the year 2021 ended with a wave of deaths of moderate intensity related to the 5th wave of COVID-19. Overall, and after a notable increase in mortality in 2020 (+9.2% compared to 2019), the pre-pandemic mortality level was approximately recovered in 2021 (+0.6% compared to 2019). Life expectancy, after declining by 10 months for men and 6 months for women in 2020, returned in 2021 to levels slightly above those of 2019 for women (85.7 years, +0.1 years from 2019) and regained 2018 levels for men (81.6 years, still -0.3 years from 2019). The age group responsible for the small remaining loss for men was the 50-70 age group, which had similar mortality in 2020 and 2021.
Conclusions The second year of the COVID-19 pandemic in Switzerland was characterized by an approximate return to pre-pandemic mortality levels, with a faster recovery for women than for men compared to 2020.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data from the Swiss Federal Statistical office : DEATHS: https://www.bfs.admin.ch/bfs/fr/home/statistiques/population/naissances-deces/deces.html POPULATION: https://www.bfs.admin.ch/bfs/fr/home/statistiques/population/effectif-evolution/age-etat-civil-nationalite.assetdetail.18344199.html and the Human Mortality Database: https://www.mortality.org/ (all specific links are provided in the section "Data" of the manuscript)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
isabella.locatelli{at}unisante.ch; valentin.rousson{at}unisante.ch
Data Availability
Swiss FSO: DEATHS: https://www.bfs.admin.ch/bfs/fr/home/statistiques/population/naissances-deces/deces.html POPULATION: https://www.bfs.admin.ch/bfs/fr/home/statistiques/population/effectif-evolution/age-etat-civil-nationalite.assetdetail.18344199.html Human Mortality Database (HMD): https://www.mortality.org/